Showing results (1121-1130 of 3,020) with videos related to
Sort By:
Pageof 302
Current Pharmaceutical Biotechnology|December 27, 2017
Biologics in Inflammatory Immune-mediated Systemic DiseasesGianluca Moroncini, Giovanni Calogera, Devis Benfaremo, et al.Current Pharmaceutical Biotechnology|February 18, 2004
Clinical applicability of mass spectrometry for inhaled carbon compounds and the characterization of trace element patterns in body fluidsWolfgang Domej, Zeno Földes-Papp, Ulrike Demel, et al.Current Pharmaceutical Biotechnology|February 18, 2004
Moderate hyperhomocysteinemia and immune activationK Schroecksnadel, B Frick, B Wirleitner, et al.Current Pharmaceutical Biotechnology|August 24, 2004
Therapeutic potential of hammerhead ribozymes in the treatment of hyper-proliferative diseasesG Grassi, P Dawson, G Guarnieri, et al.Current Pharmaceutical Biotechnology|June 25, 2005
Characterization of pharmaceutical polymorphs by isothermal calorimetryKoji UrakamiCurrent Pharmaceutical Biotechnology|April 28, 2005
NMR spectroscopy and protein structure determination: applications to drug discovery and developmentDavid WishartCurrent Pharmaceutical Biotechnology|April 28, 2005
Release kinetics from bio-polymeric nanoparticles encapsulating protein synthesis inhibitor- cycloheximide, for possible therapeutic applicationsAnita K Verma, Kumar Sachin, Anita Saxena, et al.Current Pharmaceutical Biotechnology|August 17, 2005
Neurovestibular and sensorimotor studies in space and Earth benefitsGilles Clément, Millard Reschke, Scott WoodCurrent Pharmaceutical Biotechnology|August 17, 2005
Space exercise and Earth benefitsBrandon R Macias, Eli R Groppo, Robert K Eastlack, et al.Current Pharmaceutical Biotechnology|June 23, 2006
Proteomic-based biomarker discovery with emphasis on cerebrospinal fluid and multiple sclerosisF S Berven, K Flikka, M Berle, et al.Pageof 302